论文部分内容阅读
氯巴占(clobazam)是由Lundbeck公司研发的一种苯二氮类药物。于2011年10月21日被美国食品药品监督管理局(FDA)批准上市,商品名为Onfi,用于年龄2岁及以上儿童的林-戈综合征(LGS)患者痫性发作的辅助治疗。
Clobazam is a benzodiazepine drug developed by Lundbeck. Was approved by the U.S. Food and Drug Administration (FDA) on October 21, 2011 under the trade name Onfi for the adjunctive treatment of epileptic seizures in patients with Gingko-Gendrome (LGS) in children 2 years of age and older.